Payment overview · 2025
General Payments
$281.33
21 reported records · 3 companies
Healthcare provider profile · identity verified
George Schultz, DO
Allopathic & Osteopathic Physicians|General Practice · MEDFORD, OR · NPI 1235225129
Verified facts
What the public records show
CMS Open Payments records show George Schultz, DO received $281.33 in general payments during 2025 across 21 reported records.
Gilead Sciences, Inc. accounted for 76.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Biktarvy.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Synthroid by this doctor in 2024.
Gilead Sciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Biktarvy as an associated drug or biological on 8065 records involving 2759 distinct recipient NPIs. Public Medicare Part D data also shows 230 claims for Biktarvy by this doctor in 2024.
Gilead Sciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Descovy as an associated drug or biological on 2032 records involving 589 distinct recipient NPIs. Public Medicare Part D data also shows 59 claims for Descovy by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $213.83 | 76.0% | 17 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $35.52 | 12.6% | 2 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $31.98 | 11.4% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $249.35 | 19 |
| Education | $31.98 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Biktarvy Normalized: biktarvy |
Drug | Gilead Sciences, Inc. | $49.56 | 3 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $31.98 | 2 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $19.44 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $16.08 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Biktarvy biktarvy |
2025 | Biktarvy | 2024 | 230 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| Gilead Sciences, Inc. Exact reporting entity; no affiliate inference |
2025 | Biktarvy open payments reported associated product |
CMS Open Payments — General Payments 8065 supporting records · 2759 recipient NPIs · example record 1234350766 |
Biktarvy · 2024 Exact normalized brand match · 1 Part D row |
230 | 25 |
| Gilead Sciences, Inc. Exact reporting entity; no affiliate inference |
2025 | Descovy open payments reported associated product |
CMS Open Payments — General Payments 2032 supporting records · 589 recipient NPIs · example record 1234351196 |
Descovy · 2024 Exact normalized brand match · 1 Part D row |
59 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 449 | 104 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 377 | 72 |
| Levothyroxine Sodium | Levothyroxine Sodium | 357 | 80 |
| Trazodone Hcl | Trazodone Hcl | 288 | 59 |
| Metoprolol Succinate | Metoprolol Succinate | 285 | 71 |
| Furosemide | Furosemide | 264 | 65 |
| Prednisone | Prednisone | 264 | 126 |
| Amlodipine Besylate | Amlodipine Besylate | 237 | 58 |
| Omeprazole | Omeprazole | 237 | 59 |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 230 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 209 | 46 |
| Losartan Potassium | Losartan Potassium | 208 | 53 |
| Sertraline Hcl | Sertraline Hcl | 188 | 29 |
| Meloxicam | Meloxicam | 185 | 60 |
| Lisinopril | Lisinopril | 180 | 43 |
| Potassium Chloride | Potassium Chloride | 171 | 45 |
| Pregabalin | Pregabalin | 166 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 158 | 48 |
| Metformin Hcl Er | Metformin Hcl | 155 | 30 |
| Pantoprazole Sodium | Pantoprazole Sodium | 155 | 37 |
| Risperidone | Risperidone | 154 | 19 |
| Bupropion Xl | Bupropion Hcl | 150 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 145 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 141 | 29 |
| Carvedilol | Carvedilol | 135 | 31 |
| Oxycodone Hcl | Oxycodone Hcl | 133 | 22 |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 128 | 13 |
| Tramadol Hcl | Tramadol Hcl | 126 | 29 |
| Mirtazapine | Mirtazapine | 124 | 24 |
| Dovato | Dolutegravir Sodium/Lamivudine | 123 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 120 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 119 | 41 |
| Azithromycin | Azithromycin | 118 | 68 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 117 | 30 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 111 | 80 |
| Morphine Sulfate Er | Morphine Sulfate | 110 | 13 |
| Spironolactone | Spironolactone | 103 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 102 | 20 |
| Gabapentin | Gabapentin | 101 | 31 |
| Ozempic | Semaglutide | 101 | 13 |
| Testosterone Cypionate | Testosterone Cypionate | 100 | 22 |
| Buspirone Hcl | Buspirone Hcl | 97 | 22 |
| Finasteride | Finasteride | 96 | 24 |
| Glimepiride | Glimepiride | 94 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 93 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 93 | 23 |
| Metformin Hcl | Metformin Hcl | 92 | 22 |
| Lorazepam | Lorazepam | 91 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 91 | 28 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 90 | 18 |
| Eliquis | Apixaban | 87 | 20 |
| Montelukast Sodium | Montelukast Sodium | 82 | 18 |
| Zolpidem Tartrate | Zolpidem Tartrate | 80 | 29 |
| Donepezil Hcl | Donepezil Hcl | 79 | 20 |
| Ibuprofen | Ibuprofen | 79 | 20 |
| Lamotrigine | Lamotrigine | 79 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 77 | 60 |
| Jardiance | Empagliflozin | 76 | suppressed |
| Levetiracetam | Levetiracetam | 75 | suppressed |
| Alprazolam | Alprazolam | 74 | 22 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 73 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 73 | 11 |
| Methocarbamol | Methocarbamol | 72 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 71 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 70 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 69 | 47 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 68 | 56 |
| Estradiol | Estradiol | 68 | 23 |
| Amitriptyline Hcl | Amitriptyline Hcl | 67 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 66 | 16 |
| Acyclovir | Acyclovir | 64 | 20 |
| Aripiprazole | Aripiprazole | 64 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 64 | 18 |
| Clonazepam | Clonazepam | 63 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 59 | suppressed |
| Lovastatin | Lovastatin | 56 | 14 |
| Hydrocortisone | Hydrocortisone | 54 | 16 |
| Isentress | Raltegravir Potassium | 53 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 53 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | 13 |
| Alendronate Sodium | Alendronate Sodium | 49 | 17 |
| Allopurinol | Allopurinol | 49 | 13 |
| Ondansetron Odt | Ondansetron | 49 | 15 |
| Naltrexone Hcl | Naltrexone Hcl | 48 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 48 | suppressed |
| Atenolol | Atenolol | 47 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 47 | suppressed |
| Topiramate | Topiramate | 47 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 46 | 15 |
| Xarelto | Rivaroxaban | 46 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 45 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 45 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 43 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 42 | suppressed |
| Nystatin | Nystatin | 42 | 13 |
| Tivicay | Dolutegravir Sodium | 42 | suppressed |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 41 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 41 | suppressed |
| Celecoxib | Celecoxib | 40 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 38 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 37 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 37 | 14 |
| Memantine Hcl | Memantine Hcl | 37 | suppressed |
| Metronidazole | Metronidazole | 37 | 25 |
| Baclofen | Baclofen | 36 | suppressed |
| Odefsey | Emtricitab/Rilpiviri/Tenof Ala | 36 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 34 | suppressed |
| Carbamazepine | Carbamazepine | 33 | suppressed |
| Ketoconazole | Ketoconazole | 33 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 33 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 32 | 13 |
| Abacavir-Lamivudine | Abacavir Sulfate/Lamivudine | 31 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Juluca | Dolutegravir/Rilpivirine | 30 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 29 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 29 | suppressed |
| Levofloxacin | Levofloxacin | 29 | 19 |
| Ventolin Hfa | Albuterol Sulfate | 29 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 27 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | suppressed |
| Lamivudine | Lamivudine | 26 | suppressed |
| Carbamazepine Er | Carbamazepine | 25 | suppressed |
| Phenobarbital | Phenobarbital | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | 16 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | 12 |
| Modafinil | Modafinil | 23 | suppressed |
| Torsemide | Torsemide | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Famotidine | Famotidine | 22 | suppressed |
| Glipizide | Glipizide | 22 | suppressed |
| Methotrexate | Methotrexate Sodium | 22 | suppressed |
| Simvastatin | Simvastatin | 22 | suppressed |
| Fluconazole | Fluconazole | 21 | 13 |
| Prezcobix | Darunavir/Cobicistat | 21 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 20 | suppressed |
| Temazepam | Temazepam | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 19 | suppressed |
| Naproxen | Naproxen | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 16 |
| Colchicine | Colchicine | 17 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 17 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 17 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 17 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Savella | Milnacipran Hcl | 16 | suppressed |
| Symtuza | Darunavir/Cob/Emtri/Tenof Alaf | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Atazanavir Sulfate | Atazanavir Sulfate | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Etravirine | Etravirine | 14 | suppressed |
| Methadone Hcl | Methadone Hcl | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | suppressed |
| Nevirapine Er | Nevirapine | 13 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Clobazam | Clobazam | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Isentress Hd | Raltegravir Potassium | 12 | suppressed |
| Maraviroc | Maraviroc | 12 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Risperidone Odt | Risperidone | 12 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Acetazolamide | Acetazolamide | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $281.33 · 21 records | Gilead Sciences, Inc. | BREZTRI, Biktarvy, QULIPTA, UBRELVY | 5 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Biktarvy play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error